Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Australian scientists develop genome sequencing to trace COVID-19 cases within four hours

Published 10/12/2020, 01:30 pm
Updated 10/12/2020, 01:36 pm

SYDNEY, Dec 10 (Reuters) - Australian scientists said on Thursday they had developed a rapid genome sequencing method that would cut to within four hours the time taken to trace the source of coronavirus cases, helping to quickly contain any future outbreaks.

Genome sequencing can help scientists monitor small changes in the virus at a national or international scale to understand how it is spreading and provide insight into how different cases are linked.

"When a new 'mystery' coronavirus case is identified, every minute counts," Ira Deveson, scientist at the Garvan Institute of Medical Research, said in a report, prepared in collaboration with the University of New South Wales (UNSW).

Genomic testing helps track the source of mystery cases, the ones whose source of infection remains unknown. But results often take more than 24 hours now.

The novel coronavirus genome is about 30,000 letters long, but tiny compared with the 3 billion letters that make up the DNA, or deoxyribonucleic acid, of the human genome.

The virus can alter the genetic signature of the hosts as it replicates itself inside them.

"By identifying this genetic variation, we can establish how different cases of coronavirus are linked," UNSW scientist Rowena Bull said.

Australia has largely avoided the high number of cases and deaths from the virus compared with other developed countries, cautiously easing restrictions after reporting zero local COVID-19 cases for the past several days.

It has reported just under 28,000 cases of COVID-19 and 908 deaths since the pandemic began but estimates there are fewer than 50 active cases remaining, mostly returned travelers from overseas in hotel quarantine.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.